Arrowstreet Capital, Limited Partnership Amgen Inc Transaction History

Arrowstreet Capital, Limited Partnership

$108 Billion
Q1 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Amgen Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 3,690 shares of AMGN stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,690

Holding current value

$1.15 Million

% of portfolio

0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $992,130 - $1.2 Million	3,690 New	3,690 $1.05 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $48.4 Million - $57.2 Million	-225,672 Reduced 33.02%	457,796 $102 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $59.7 Million - $72.8 Million	-264,568 Reduced 27.91%	683,468 $165 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $140 Million - $178 Million	-612,439 Reduced 39.25%	948,036 $249 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $43.7 Million - $49.3 Million	194,773 Added 14.26%	1,560,475 $352 Million

Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $6.4 Million - $7.12 Million	27,732 Added 2.07%	1,365,702 $332 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $183 Million - $202 Million	832,885 Added 164.9%	1,337,970 $324 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $32 Million - $36.7 Million	161,037 Added 46.81%	505,085 $114 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $80.6 Million - $94.4 Million	-379,693 Reduced 52.46%	344,048 $73.2 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $169 Million - $188 Million	723,741 New	723,741 $176 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $510,393 - $594,780	-2,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $497,674 - $592,641	2,300 New	2,300 $529,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $1.71 Million - $1.9 Million	-7,298 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $14.1 Million - $17.3 Million	-71,153 Reduced 90.7%	7,298 $1.72 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $10.2 Million - $13.5 Million	55,953 Added 248.7%	78,451 $15.9 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $126 Million - $162 Million	-667,339 Reduced 96.74%	22,498 $5.42 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $226 Million - $271 Million	-1,298,709 Reduced 65.31%	689,837 $133 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $96.9 Million - $114 Million	581,435 Added 41.32%	1,988,546 $366 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $86.8 Million - $97.8 Million	479,659 Added 51.72%	1,407,111 $267 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $163 Million - $190 Million	913,652 Added 6620.67%	927,452 $181 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $1.43 Million - $1.61 Million	7,700 Added 126.23%	13,800 $2.86 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $1.01 Million - $1.14 Million	6,100 New	6,100 $1.13 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $16.4 Million - $19.2 Million	-97,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $15.5 Million - $17.4 Million	92,100 Added 1879.59%	97,000 $16.9 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $819,721 - $935,900	4,900	4,900 $914,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Amgen Inc Transaction History